<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Relmada Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Relmada Therapeutics, Inc.

    We are a clinical stage, publicly traded specialty pharmaceutical company, focused on developing dextromethadone (REL-1017) as a rapid-acting oral treatment for depression, CNS and ophthalmological disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Sergio Traversa, PharmD, MBA
    • FOUNDED
      2004
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Corvus Pharmaceuticals, Inc.

    Corvus Pharmaceuticals, Inc.

    Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company. We ...

    Corvus Pharmaceuticals is a clinical science-dr...

    Filing Type:    PU
    Interpace Diagnostics Group, Inc.

    Interpace Diagnostics Group, Inc.

    Interpace Diagnostics is focused on developing and commercializing molecular diagn...

    Interpace Diagnostics is focused on developing ...

    Filing Type:    PU
    Millendo Therapeutics, Inc.

    Millendo Therapeutics, Inc.

    Millendo Therapeutics is a late-stage biopharmaceutical company primarily focused ...

    Millendo Therapeutics is a late-stage biopharma...

    Filing Type:    PU
    Miragen Therapeutics, Inc.

    Miragen Therapeutics, Inc.

    miRagen Therapeutics, Inc., is a clinical stage biopharmaceutical company discover...

    miRagen Therapeutics, Inc., is a clinical stage...

    Filing Type:    PU
    Ocular Therapeutix, Inc.

    Ocular Therapeutix, Inc.

    Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on ...

    Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a bi...

    Filing Type:    PU
    Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc.

    Marinus Pharmaceuticals, Inc. is committed to improving the lives of patients suff...

    Marinus Pharmaceuticals, Inc. is committed to i...

    Filing Type:    PU
    Sage Therapeutics, Inc.

    Sage Therapeutics, Inc.

    Sage Therapeutics is a biopharmaceutical company committed to developing novel the...

    Sage Therapeutics is a biopharmaceutical compan...

    Filing Type:    PU
    Fisher Wallace Laboratories, Inc.

    Fisher Wallace Laboratories, Inc.

    Fisher Wallace manufactures and markets wearable medical devices for the treatment...

    Fisher Wallace manufactures and markets wearabl...

    Amount Raised:    $670,653.00
    Fundraising Status:    EC
    Filing Type:    CF
    Axsome Therapeutics, Inc.

    Axsome Therapeutics, Inc.

    Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing...

    Axsome Therapeutics, Inc. is a clinical-stage b...

    Filing Type:    PU
    Alkermes plc

    Alkermes plc

    Alkermes plc is a fully integrated, global biopharmaceutical company developing in...

    Alkermes plc is a fully integrated, global biop...

    Filing Type:    PU
    Auris Medical Holding Ltd.

    Auris Medical Holding Ltd.

    We at Auris Medical are dedicated to developing novel pharmaceutical products for ...

    We at Auris Medical are dedicated to developing...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.